Semaglutide guidelines based on BMI may exclude at-risk Indians
Global semaglutide eligibility criteria based on BMI may not reflect Indian risk patterns, potentially excluding high-risk patients who develop cardiovascular disease at lower body weights |Image used for representational purpose only | Photo Credit: AFP The SELECT trial, led by A. Michael Lincoff and published in The New England Journal of Medicine (2023), showed that…
Read More “Semaglutide guidelines based on BMI may exclude at-risk Indians” »